Compare AGRO & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGRO | FLGT |
|---|---|---|
| Founded | 2002 | 2011 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 813.7M | 697.3M |
| IPO Year | 2011 | 2016 |
| Metric | AGRO | FLGT |
|---|---|---|
| Price | $7.38 | $27.09 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $8.17 | ★ $28.33 |
| AVG Volume (30 Days) | ★ 1.1M | 272.3K |
| Earning Date | 11-11-2025 | 11-07-2025 |
| Dividend Yield | ★ 4.91% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $1,386,018,000.00 | $315,549,000.00 |
| Revenue This Year | N/A | $16.84 |
| Revenue Next Year | N/A | $9.74 |
| P/E Ratio | $30.64 | ★ N/A |
| Revenue Growth | N/A | ★ 13.61 |
| 52 Week Low | $6.89 | $14.57 |
| 52 Week High | $11.79 | $31.04 |
| Indicator | AGRO | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 40.99 | 47.68 |
| Support Level | $6.89 | $26.63 |
| Resistance Level | $7.65 | $31.04 |
| Average True Range (ATR) | 0.38 | 0.75 |
| MACD | -0.10 | -0.41 |
| Stochastic Oscillator | 23.64 | 12.80 |
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.